Loading insider details...
Latest Form 4 (Nov 4, 2026): Grant/Award of 150,000 NRXP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | NRX Pharmaceuticals, Inc. (NRXP) | Grant/Award | 150,000 | n/a |
| Sep 10, 2025 | NRX Pharmaceuticals, Inc. (NRXP) | Grant/Award | 125,000 | n/a |
| Dec 18, 2024 | NRX Pharmaceuticals, Inc. (NRXP) | Purchase | 40,000 | $46.8K |
| Aug 24, 2023 | NRX Pharmaceuticals, Inc. (NRXP) | Purchase | 100,000 | $33.0K |
| Aug 23, 2023 | NRX Pharmaceuticals, Inc. (NRXP) | Purchase | 200,000 | $64.4K |
| Dec 9, 2022 | NRX Pharmaceuticals, Inc. (NRXP) | Sale | 400,000 | $400.0K |
| Jun 2, 2022 | NRX Pharmaceuticals, Inc. (NRXP) | Purchase | 100,000 | $5.80M |
| Jun 10, 2021 | NRX Pharmaceuticals, Inc. (NRXP) | Grant/Award | 46,332 | n/a |